Navigation Links
Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
Date:11/27/2007

- Significant clinical progress noted in small cell lung, prostate and

colorectal cancer trials -

SOUTH SAN FRANCISCO, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today provided an update of its picoplatin development program in small cell lung cancer (SCLC), colorectal cancer (CRC) and hormone refractory prostate cancer (HRPC), and its oral formulation in solid tumors. Presenting at the Lazard Capital Markets Healthcare Conference in New York, Jerry McMahon, Ph.D., chairman and CEO of Poniard, noted that the Company has made significant progress in 2007 in its clinical development program for picoplatin, its lead product candidate.

"2007 has been an important year for Poniard, as we have continued to advance our development of picoplatin, a new generation chemotherapy agent with the potential to become a platform product addressing multiple indications, combinations and formulations," said Dr. McMahon. "We continue to drive our clinical programs toward completion and have achieved significant milestones this year. In addition, we remain on track to file our NDA for picoplatin in 2009."

Poniard is providing an update on the progress on all four of its picoplatin clinical trials, as follows:

Phase 3 SPEAR Trial:

Poniard is evaluating intravenous picoplatin in an ongoing pivotal Phase 3 trial, known as SPEAR (Study of Picoplatin Efficacy After Relapse), in SCLC. This registrational trial is being conducted under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA) and is evaluating overall survival as the primary endpoint.

To date
'/>"/>

SOURCE Poniard Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Eli Lilly and Company (NYSE: LLY ) today ... its intent to end its contract with the university ... Alzheimer,s disease (A4) study. The A4 study is a ... of Alzheimer,s disease in older individuals who have evidence ... but do not show symptoms of memory impairment. A4 ...
(Date:8/4/2015)... SAN FRANCISCO, Calif. , Aug. 4, 2015 /PRNewswire/ ... results for the second quarter and six months ended ... studies with fostamatinib in ITP are progressing and we ... said Raul Rodriguez , president and chief executive ... advancement of our other clinical programs, including evaluating fostamatinib ...
(Date:8/4/2015)... Research and Markets ... the "MRI Systems Market to 2020 - ... Growth Driven by Developing Economies" report to ... 2020 - Focus on Patient Comfort and Operational ... the market, competitive landscape, and trends for three ...
Breaking Medicine Technology:Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3Rigel Announces Second Quarter 2015 Financial Results 2Rigel Announces Second Quarter 2015 Financial Results 3Rigel Announces Second Quarter 2015 Financial Results 4Rigel Announces Second Quarter 2015 Financial Results 5Rigel Announces Second Quarter 2015 Financial Results 6Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2
... VEGAS, Jan. 5, 2011 One person age 65 and older ... Center for Disease Control, falls are the leading cause of ... most common cause of nonfatal injuries and hospital admissions for trauma. ... expected to more than double to 89 million by 2050 - ...
... 5, 2011 SyncMedical LLC today announced ... – Brazilian National Health Surveillance Agency) has approved their ... in Brazil. SyncMedical,s Ethos Spine product line was developed ... treatment solutions to surgeons in the ever-growing, ever-changing field ...
Cached Medicine Technology:SecuraTrac Reveals Revolutionary Safety Solution Based on GPS & Cellular Technology at CES 2011 2SecuraTrac Reveals Revolutionary Safety Solution Based on GPS & Cellular Technology at CES 2011 3SyncMedical Receives ANVISA Regulatory Approval to Offer Spine and Internal Medicine Products in Brazil 2
(Date:8/4/2015)... , ... August 05, 2015 , ... ... Texas-based corporation, Crestwood Midstream, to store liquid propane gas (LPG) next to Seneca ... healthcare workers union, unanimously passed a resolution that strongly opposes that permit. *, ...
(Date:8/4/2015)... ... ... review site BestMillionaireDatingSites.com recently refreshed its list of the top dating platforms for wealthy ... service in the segment. , A representative from the site said, “You certainly cannot ... right dating platform so that they can make the most of it and find ...
(Date:8/4/2015)... , ... August 04, 2015 , ... NOVA Pride ... of whom or how they love or identify, to join them in paving “The ... Bull Run Special Events Center on Saturday, October 3, 2015, from 12-9pm. In order ...
(Date:8/4/2015)... ... ... Statement by Paul Gionfriddo, President and CEO, Mental Health America , " Mental ... 2015 by Senators Bill Cassidy and Christopher Murphy. It is another important ... legislation and H.R. 2646 [The Helping Families in Mental Health Crisis Act ...
(Date:8/4/2015)... , ... August 04, 2015 , ... Sponsored by Gila ... AZ, which is a 501(c) nonprofit organization. , According to the New Foundation ... Sponsors will get a package that includes a complimentary foursome for the tournament, as ...
Breaking Medicine News(10 mins):Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 2Health News:Opposition Mounting to Permit Liquid Propane Gas Storage Next to New York’s Seneca Lake 3Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 4Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3
... few minutes of exercise every day could help improve fitness ... US scientists say. ,Conducting tests on overweight and ... at Louisiana State University, Baton Rouge found that even ten ... them up enough to lower their overall risk of early ...
... broccoli, Brussel sprouts, cauliflower and green cabbage are known ... . But, researchers have now warned that boiling these ... ,Brassica vegetables have a high concentration of substances ... substances known as isothiocyanates. ,However before ...
... had better be taken heed of, by bosses. The study ... lead to dire consequences, like a heart attack. ... University College London and published in the Journal of Epidemiology ... servants working in London for almost 11 years. ...
... percent of U.S. adults may have some form of ... about 2.4 percent with a "sub-threshold" condition, according ... General Psychiatry. ,Individuals with bipolar disorder tend ... characterized by impulsive behavior and an increased activity leveland ...
... for any person depends on his physiology . ... Weight for Life Program at Children's Hospital Boston, who says ... all', also notes that heavy people with an apple shape ... a lot more pounds on a diet that excluded processed ...
... new study of chemo patients, scientists at the Georgia Institute ... a gene , p53, thought to be essential in helping ... ,The researchers found that 70 percent of subjects whose ... after five years. Patients with normal p53 displayed only a ...
Cached Medicine News:Health News:Boiling Makes Broccoli to Loses Its Anticancer Properties 2Health News:Feelings Of Injustice At Work Can Lead To A Heart Attack 2Health News:More Than Four Percent of US Adults Have Some Form of Bipolar Disorder 2Health News:More Than Four Percent of US Adults Have Some Form of Bipolar Disorder 3Health News:Check Your Physiology Before You Choose A Diet 2Health News:Gene Thought to Help Kill Cancer Cells may Actually Help Them Thrive 2
... Stenoscop Plus is a truly flexible ... a wide range of applications, inlcuding orthopedics, ... stent placement, and more. , ... image intensifier sizes, evolutive memory capacities and ...
Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus....
Provides quick freezing and quick defrosting. Lightweight probe tips have high conductivity silver. Useful for Cataract, Retinal Detachment, Glaucoma and Intra-vitreal surgery. Includes either one ca...
Khosla Precision and Quality in Medical and Surgical Products....
Medicine Products: